DPP4 and obesity due to melanocortin 4 receptor deficiency: Moreover, DPP4 inhibition has proven beneficial in experimental models of diabetes23 and obesity-associated renal dysfunction24,25, suggesting that DPP4 plays a role in a common mechanism underlying the development and progression of kidney disease.